The CHMP issues positive opinion to expand INVOKANA® and VOKANAMET® labels to include positive data on cardiovascular and renal outcomes

Aug 02 2018

INFORMATION FOR EUROPEAN MEDICAL/TRADE ONLY| PDF iconDownload PDF